The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 528 KB) and Technical Notes (PDF, 794 KB) pages.


Download and Print: Download Printer-friendly PDF


Section 30

Myelodysplastic Syndromes (MDS), Chronic Myeloproliferative Disorders (CMD), and

Chronic Myelomonocytic Leukemia (CMML)

This section includes Myelodysplastic Syndromes (MDS), Chronic Myeloproliferative Disorders (CMD), and Chronic Myelomonocytic Leukemia (CMML). In the 3rd edition of the International Classification of Diseases for Oncology, the behavior code of myelodysplastic syndromes and chronic myeloproliferative disorders was changed from /1, borderline malignancy or low malignant potential, to /3, malignant primary site. These diagnoses became reportable for cases diagnosed in 2001+ when ICD-O-3 went into effect. CMML has been reportable for all years. CMML is included here and in the leukemia section.

Page Navigation: << Previous Next >>


The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.